WuXi PharmaTech has acquired NextCODE Health to create WuXi NextCODE Genomics, a global leader in genomic medicine. Pairing WuXi’s technology and existing reach with NextCODE’s leading analytics and database promises to advance the pace of genomics research today.

1. A
new
era,
new
vision
for
WuXi
and
NextCODE
Health
Hannes
Smarason
Genome
Sequencing
|Personalized
Medicine
|
Transforming
Health
Care

2. Our
Opportunity:
Enhance
Value
of
Genomics
in
Medicine
In
the
fast-­‐paced
genomics
community,
we
con?nually
look
for
new
opportuni?es
and
strategies
to
enhance
the
value
of
genomics
and
use
the
increasingly
robust
body
of
genomic
data
for
the
advancement
of
clinical
medicine.
We’re
excited
to
announce
a
new,
ambi?ous
vision
to
do
just
that,
with
WuXi’s
acquisi?on
of
NextCODE
Health.

3. NextCODE
and
WuXi
• NextCODE
will
be
merged
with
WuXi’s
exis?ng
Genome
Center
in
wholly-­‐owned
subsidiary
called
WuXi
NextCODE
Genomics,
with
unique,
comprehensive
and
global
capabili?es
for
using
genomic
data
to
deliver
beOer
medicine
and
improve
healthcare.

4. Increased
Value
Through
CollaboraIon
• WuXi,
a
Shanghai-­‐based
genomic
laboratory
service
partner
for
companies
in
the
pharma
and
biotech
community,
has
already
been
collabora?ng
with
NextCODE
to
provide
analysis
services
to
customers
of
the
WuXi
Genome
Center.
• Now,
with
the
in-­‐house
capability
to
analyze,
store
and
manage
the
vast
amount
of
genomic
data,
NextCODE’s
industry
leading
genome
sequence
analysis
plaPorm
will
expand
WuXi’s
core
NGS
benefits
and
services.

5. Enhancing
CapabiliIes
and
ContribuIons
• Pairing
WuXi’s
technology
and
exis?ng
reach
with
NextCODE’s
leading
analy?cs
and
database
promises
to
advance
the
pace
of
genomics
research
today.
• More
importantly,
however,
this
new
era
for
our
company
brings
exci?ng
opportuni?es
to
maximize
the
most
advanced
tools
available
today
and
contribute
to
major
advances
in
genomic
medicine.